Who we are
EndoGen Constructs began over coffee-amplified long run chats between its two co-founders. Excited by the potential synergies between metamaterials and tissue engineering, we began discussing ideas to enable medical professionals. We are tackling the opportunity from both ends, we have a novel idea for 3d bioprinting and believe there are opportunities to fundamentally speed up and reduce the cost of surgical tool development.
Non-invasive, surgical tissue repair is poised for a regenerative medicine revolution. Availability of suitable cell sources, biomaterials, and fabrication methods for functional engineered tissues continues to expand. However, there are few clinically active examples using these approaches. There is an opportunity to redefine surgical possibility and access by delivering the first in vivo bioprinter and a standardized pathway from cellular bioink to patient delivery.
Advances in optics and acoustics have made holographic assembly and functional interrogation of engineered tissues possible. Translating these technologies to a clinical platform and standardizing bioink delivery methodology across the regeneration field is the challenge. We are currently focused on working with R&D labs interested in our proposed printing and characterization method as we optimize the design to fit a clinical form factor.
Within the medical device and regulatory space, we are also consulting on pediatric surgical tool design, with a focus on reducing costs at every point in the development process, a crucial step in increasing the number of surgeon ideas that can positively impact pediatric outcomes. We hope to improve the surgical care options for this patient population by fundamentally changing the path from prototype to product for these devices.
Rapid Translation of R&D to the clinic.
Surgical solutions.
Access for all patient populations.
Meet the Team
-
Founder
-PhD, Materials Science and Engineering, Boston University and Boston Children’s Hospital
-Formerly SVP R&D at Novoheart, a stem cell biotechnology company focused on cardiac tissue engineering for drug testing and disease modeling (2018-2024)
-Technical expertise in scaffolds for tissue engineering and mechanical characterization, bio-MEMS devices for cellular functional measurements, biomedical device design (focus on cardiac tissues and contractility measurements), biomaterial and tissue mechanical properties
-
Founder
-PhD, Applied Physics, California Institute of Technology
-Currently a postdoctoral researcher at NYU Langone (metaoptics / biomedical imaging research)
-Prior to PhD, worked at Magic Leap, an augmented reality startup, on implementing optimized computer vision and deep learning algorithms
-Technical expertise in volumetric optical metasurfaces (electromagnetic simulation / design, nanofabrication, optical measurements), two photon lithography printing, embedded and general software engineering